Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Smolkin

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Cancer|April 27, 2005
Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapyNicole Miller, Mark E Smolkin, Eric Bissonette, et al.
International Journal of Radiation Oncology, Biology, Physics|September 13, 2006
Case-matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancerSophie G Fletcher, Stacey E Mills, Mark E Smolkin, et al.
Metabolism Open|November 24, 2025
Using metabolic syndrome severity in the "real world": Associations with diabetes and cardiovascular disease in all of us vs. NHANESMark D DeBoer, Matthew J Gurka, Marieke K Jones, et al.
The American Journal of Surgical Pathology|August 30, 2008
Comprehensive evaluation of CDX2 in invasive cervical adenocarcinomas: immunopositivity in the absence of overt colorectal morphologyLisa M Sullivan, Mark E Smolkin, Henry F Frierson, et al.
BJU International|March 24, 2007
Atypical small acinar proliferation: biopsy artefact or distinct pathological entity?Sarah C Flury, Mary T Galgano, Stacey E Mills, et al.
Comprehensive Psychoneuroendocrinology|May 22, 2026
Metabolic syndrome severity is related to perceived discrimination and stress in the all of us cohortMark D DeBoer, Matthew J Gurka, Mark E Smolkin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 3, 2015
The Risk Factors of Readmission in Postoperative Gynecologic Oncology Patients at a Single InstitutionJohn M Nakayama, Jennie P Ou, Caroline Friedman, et al.
Cancer Immunology, Immunotherapy : CII|September 23, 2015
Defining the effects of age and gender on immune response and outcomes to melanoma vaccination: a retrospective analysis of a single-institution clinical trials' experienceAdriana G Ramirez, Nolan A Wages, Yinin Hu, et al.
The Laryngoscope|February 12, 2016
Prognostic value of albumin in patients with head and neck cancerDeepa Danan, David C Shonka, Yamil Selman, et al.
Academic Radiology|July 26, 2005
Evaluating hormone therapy-associated increases in breast density comparison between reported and simultaneous assignment of BI-RADS categories, visual assessment, and quantitative analysisJennifer A Harvey, Viktor E Bovbjerg, Mark E Smolkin, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Cancer|April 27, 2005
Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapyNicole Miller, Mark E Smolkin, Eric Bissonette, et al.
International Journal of Radiation Oncology, Biology, Physics|September 13, 2006
Case-matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancerSophie G Fletcher, Stacey E Mills, Mark E Smolkin, et al.
Metabolism Open|November 24, 2025
Using metabolic syndrome severity in the "real world": Associations with diabetes and cardiovascular disease in all of us vs. NHANESMark D DeBoer, Matthew J Gurka, Marieke K Jones, et al.
The American Journal of Surgical Pathology|August 30, 2008
Comprehensive evaluation of CDX2 in invasive cervical adenocarcinomas: immunopositivity in the absence of overt colorectal morphologyLisa M Sullivan, Mark E Smolkin, Henry F Frierson, et al.
BJU International|March 24, 2007
Atypical small acinar proliferation: biopsy artefact or distinct pathological entity?Sarah C Flury, Mary T Galgano, Stacey E Mills, et al.
Comprehensive Psychoneuroendocrinology|May 22, 2026
Metabolic syndrome severity is related to perceived discrimination and stress in the all of us cohortMark D DeBoer, Matthew J Gurka, Mark E Smolkin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 3, 2015
The Risk Factors of Readmission in Postoperative Gynecologic Oncology Patients at a Single InstitutionJohn M Nakayama, Jennie P Ou, Caroline Friedman, et al.
Cancer Immunology, Immunotherapy : CII|September 23, 2015
Defining the effects of age and gender on immune response and outcomes to melanoma vaccination: a retrospective analysis of a single-institution clinical trials' experienceAdriana G Ramirez, Nolan A Wages, Yinin Hu, et al.
The Laryngoscope|February 12, 2016
Prognostic value of albumin in patients with head and neck cancerDeepa Danan, David C Shonka, Yamil Selman, et al.
Academic Radiology|July 26, 2005
Evaluating hormone therapy-associated increases in breast density comparison between reported and simultaneous assignment of BI-RADS categories, visual assessment, and quantitative analysisJennifer A Harvey, Viktor E Bovbjerg, Mark E Smolkin, et al.
Pageof 7